GUIDED THERAPEUTICS, INC. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- GUIDED THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2026-03-31 was $203.00K, a 138.82% increase year-over-year.
- GUIDED THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2025-03-31 was $85.00K.
- GUIDED THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2020-09-30 was $50.00K.
- GUIDED THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2020-06-30 was $625.00K, a 681.25% increase year-over-year.
- GUIDED THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2025 was $900.00K.
- GUIDED THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2019 was $33.00K.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2026-03-31 | $203.00K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $900.00K 10-K · filed 2026-03-31 | |
| 2025-03-31 | $85.00K 10-Q · filed 2026-05-15 | |
| 2020-09-30 | $50.00K 10-Q/A · filed 2020-11-05 | |
| 2020-06-30 | $625.00K 10-Q · filed 2020-08-20 | |
| 2020-03-31 | $2.08M 10-Q/A · filed 2021-08-18 | |
| 2019-12-31 | $33.00K 10-K · filed 2021-04-07 | |
| 2019-09-30 | -$3.00K 10-Q/A · filed 2020-11-05 | |
| 2019-06-30 | $80.00K 10-Q · filed 2020-08-20 | |
| 2019-03-31 | $34.00K 10-Q · filed 2020-07-07 |